Biblio
2024
Dunbar AJ, Bowman RL, Park YC, O'Connor K, Izzo F, Myers RM, Karzai A, Zaroogian Z, Kim WJun, Fernández-Maestre I, et al. Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms. Cancer Discov. 2024.
2023
Dunbar A, Kim D, Lu M, Farina M, Bowman RL, Yang JL, Park YC, Karzai A, Xiao W, Zaroogian Z, et al. CXCL8/CXCR2 signaling mediates bone marrow fibrosis and represents a therapeutic target in myelofibrosis. Blood. 2023.